Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.77 |
| ▸ | NSD2 | O96028 | 1/20 | 0.77 |
| ▸ | TDO2 | P48775 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fustin SCHEMBL555237 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL29929489 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL13583362 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL30443589 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| SCHEMBL12378836 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| SCHEMBL12417567 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL29370332 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL9663852 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL29929200 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Dihydrobinetin SCHEMBL18177341 | 0.87 | SYNJ2 (0.64) | IDO1NSD2TDO2KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | IMMUNOLUX INTERNATIONAL CORP. | 2023-02-09 | — | — | US | disclosed |
| CN-114965817-A | Method for rapidly identifying chemical components of unknown flavonoids in camptotheca acuminata | 四川农业大学 | 2022-08-30 | — | — | CN | disclosed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | disclosed |
| US-8859014-B2 | Method of converting fustin to fisetin | AZI COMPANY LTD. (KR) | 2014-10-14 | — | — | US | disclosed |
| US-8859014-B2 | Method of converting fustin to fisetin | AZI COMPANY LTD. (KR) | 2014-10-14 | — | — | US | disclosed |
| US-20140031567-A1 | Method of Converting Fustin to Fisetin | AZI COMPANY LTD. (KR) | 2014-01-30 | — | — | US | disclosed |
| US-20140031567-A1 | Method of Converting Fustin to Fisetin | AZI COMPANY LTD. (KR) | 2014-01-30 | — | — | US | disclosed |
| US-8551537-B2 | Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same | AZI COMPANY LTD. (KR) | 2013-10-08 | — | — | US | disclosed |
| US-8551537-B2 | Rhus verniciflua stokes extract having increased content of active flavonoid compound and method for preparing same | AZI COMPANY LTD. (KR) | 2013-10-08 | — | — | US | disclosed |
| US-20120283322-A1 | Rhus Verniciflua Stokes Extract Having Increased Content Of Active Flavonoid Compound And Method For Preparing Same | AZI COMPANY LTD. (KR) | 2012-11-08 | — | — | US | disclosed |
| US-20120283322-A1 | Rhus Verniciflua Stokes Extract Having Increased Content Of Active Flavonoid Compound And Method For Preparing Same | AZI COMPANY LTD. (KR) | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283322-A1 | Rhus Verniciflua Stokes Extract Having Increased Content Of Active Flavonoid Compound And Method For Preparing Same | FUS, FLOT1, FIS1 | IDO1 4816/4885NSD2 1688/4885TDO2 4645/4885 |
| US-20230040081-A1 | VACCINIA VIRAL POLYMERASE-MEDIATED VIRAL REPLICATION | POLR1G, POLR1A, POLR1E | IDO1 3079/4885NSD2 3205/4885TDO2 2459/4885 |
| US-20140031567-A1 | Method of Converting Fustin to Fisetin | FUS, RFTN1, HRAS | IDO1 4869/4885NSD2 1612/4885TDO2 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.